Sign in

CIK 0001770069 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

MapLight Therapeutics, Inc.

Sign in to watch
Ticker
MPLT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
832163243
Phone
650-839-4360
Business address
800 CHESAPEAKE DRIVE, REDWOOD CITY, CA, 94063
Former names
Alvarado Therapeutics, Inc.
  1. 4 Planned sale Chief Executive Officer sold 49,744 shares at an average $28.39 ($1,412,236)
  2. 4 Planned sale CAAO and PAO sold 69,835 shares at an average $29.89 ($2,087,687)
  3. 4 Planned sale Chief Discovery Officer sold 45,422 shares at an average $29.66 ($1,347,066)
  4. 4 Open-market sale Chief Discovery Officer sold 3,316 shares at $26.61 ($88,239)
  5. 4 Open-market sale CAAO and PAO sold 3,590 shares at $26.61 ($95,530)
  6. 4 Open-market sale General Counsel sold 1,827 shares at an average $26.89 ($49,134)
  7. 4 Open-market sale Chief Financial Officer sold 2,922 shares at an average $26.89 ($78,572)
  8. 4 Open-market sale Chief Scientific Officer sold 4,513 shares at an average $27.16 ($122,574)
  9. 4 Open-market sale Chief Medical Officer sold 3,213 shares at an average $27.03 ($86,859)
  10. 4 Open-market sale Chief Executive Officer sold 19,187 shares at an average $27.16 ($521,146)
  11. 4 Planned sale Director sold 8,593 shares at $26.90 ($231,152)
  12. 4 Open-market sale Director sold 14,195 shares at an average $18.34 ($260,398)
  13. 4 Open-market buy Director bought 25,000 shares at an average $17.65 ($441,168)
  14. 4 Open-market sale Director sold 12,116 shares at $18.21 ($220,632)
  15. 4 Open-market buy Director bought 14,124 shares at $17.89 ($252,678)
  16. 4 Open-market sale Director sold 6,863 shares at an average $18.12 ($124,329)
  17. 4 Grant or award CAAO and PAO acquired 6,020 shares (grant or award)
  18. 4 Grant or award Chief Financial Officer acquired 7,730 shares (grant or award)
  19. 4 Grant or award Chief Scientific Officer acquired 7,730 shares (grant or award)
  20. 4 Grant or award Chief Discovery Officer acquired 6,020 shares (grant or award)

Page 3 of 5 · 100 filings